Rxid » market share

Pharmaceutical Markets in India

admin — Sat, 16 Jan 2010 07:57:49 +0000

The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. ( http://www.bharatbook.com/Market-Research-Reports/Pharmaceutical-Markets-in-India.html )

This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including: * Market Size and Forecast * Indian Market Share of Key Competitors * Population and Epidemilogical Statistics for the Indian Market * Pharmaceutical Market by Product Category * Company Profiles of Global Companies * Profiles of Key Domestic (Indian) Companies The report includes incidence of conditions prevalent in the region discussed, health statistics related to the industry, birth rates, world population, regional population and issues affecting the market as a whole. Provided is an overview of demographics, information about products segments and market indicators, market estimates and forecasts. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Contact us at :Bharat Book Bureau Tel: +91 22 27578668Fax: +91 22 27579131Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
Hummer Parts

Active Pharmaceutical Ingredients Market in North America

admin — Sat, 16 Jan 2010 01:59:36 +0000

North American Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020 This report provides in-depth analysis of the North American active pharmaceutical ingredients (API) market and presents revenue forecasts up to 2020 for the United States and Canada. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole North American market is also covered in the report. ( http://www.bharatbook.com/Market-Research-Reports/North-America-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts-to-2020.html ) Economic Crisis Slows the Revenue Growth of the North American API Market The current global economic crisis has negatively affected the North American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings of the healthcare expenditure, there is a shift away from the high-priced innovative drugs in the United States and Canada. This has resulted in a significant slowdown in the revenue growth of the North American API market. In 2009, the North American API market is set grow at a rate of around 2%. Biotech APIs Set to Drive the Overall Growth of the API Market in North America The biotech API market in North America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for the biological drugs is boosting the demand for the biotech API in the market place. Also, the technological advancement in the pharmaceutical industry is paving way for newer biotechnology drugs. The pharmaceutical industry is also optimistic about the approval of biogeneric drugs which is expected to create further growth in the development of the biotech API market. This will boost the growth of the biotech API market making it to grow at a rate significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 13% from 2008 to 2020. Generic APIs Get a Boost Due to the Cost-Containment Measures in North America Canada Poised to Increase its Revenue Share in the North American API Market The Canadian API market, which held a revenue share of around 6% in 2008, is bound to increase its share to 7% in 2015. The Canadian API market is characterized by an emerging biotech API product segment which is growing fastest in the North American market. Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com

Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US

admin — Sun, 10 Jan 2010 19:51:07 +0000

Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world. And according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, the new research report, the potential and opportunities in this market are expected to increase several fold in the next five years. ( http://www.bharatbook.com/Market-Research-Reports/Market-Potential-for-Hospital-Services-Pharmaceuticals-and-Medical-Devices-in-US.html ) This report provides factual insight supplemented with statistical overview on the past, present and future market. It studies the entire structure, composition and working of the US healthcare sector and describes the potential of hospital services, pharmaceuticals and medical devices in the market. This report discusses the demand, market size and future prospects of nearly every major sector, like cardiovascular, diabetes, musculoskeletal, oncology, wound care management, cosmetic surgery, dental health, and in vitro diagnostics, in the US healthcare market. It identifies key opportunities and roadblocks that will affect the future direction of the market. “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” thus serves as a guide for healthcare service providers/drug manufactures/investors who are planning to enter the US healthcare market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles. Key Findings of the Report * Total healthcare spending in the US is expected to grow at a CAGR of 7% between 2007 and 2012. * Around 43 Million people are expected to be above 65 years of age in the US by 2012, thereby increasing the prevalence of several chronic diseases. * Around 122 Million Americans are expected to suffer from cardiovascular diseases by 2012, leading to direct expenses of over US$ 414 Billion. * The US, with over 19 Million diabetics by 2012, is expected to fuel the growth of the diabetes drugs and monitoring devices market. * Driven by target-based therapies with negligible side effects, the US oncology market is amongst the fastest growing sectors in the healthcare industry. * The aging baby boomers, coupled with an increasing incidence of hip and knee fractures, are expected to strongly drive the musckoskeletal market. * Driven by a need to look young and attractive, both surgical and non-surgical cosmetic procedures are becoming highly popular. Key Issues & Facts Analyzed in the Report * Evaluation of past, current and future market trends. * Market evaluation by type of disease. * Discussion on the major drivers of the healthcare market. * Identification and evaluation of the opportunities created by the market. * Analysis of major challenges for the market. To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Market-Potential-for-Hospital-Services-Pharmaceuticals-and-Medical-Devices-in-US.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook

Chinese Pharmaceutical Market Outlook 2009-2024

admin — Wed, 06 Jan 2010 02:09:24 +0000

Chinese Pharmaceutical Market Outlook 2009-2024 In November 2008, China announced a major economic stimulus package, including $124bn to be spent on healthcare. These changes will have a major impact on the Chinese pharmaceutical landscape over the next 15 years, as the stimulus increases the number of clinics in rural areas, dissociates pharmacies from hospitals and promises healthcare coverage to 100% of the population by 2020. This report – Chinese Pharmaceutical Market Outlook 2009-2024 – analyses prospects for the pharma market and industry sector in China. This new study discusses market drivers and restraints such as production capacity, intellectual property rights and the high, fast-growing healthcare demands in China. Importantly, we provide detailed sales forecasting at the core of the analyses. As both a large producer and consumer of a wide range of medicines, China is now a crucial player in the global pharmaceutical market and industry. China is still a challenging environment for foreign companies, investors and purchasers. Will the great potential benefits offered by China outweigh its drawbacks as a pharma market? Yes they will – but how and why? Read this report to find out. ( http://www.bharatbook.com/Market-Research-Reports/Chinese-Pharmaceutical-Market-Outlook-2009-2024.html ) China’s rising significance in the global pharma market will make it a vital market for international pharmaceutical companies to enter and expand. China’s efforts to reinvent its healthcare system will change the way pharmaceuticals are marketed and sold throughout the country. However, those changes will not take place immediately. What will happen first? For example, how will prescription of antibiotics change? Also, what impact will reported quality concerns and counterfeiting have on China’s pharmaceutical sector? Comprehensive analysis of the Chinese pharma sector Chinese Pharmaceutical Market Outlook 2009-2024 examines that sector critically, through a comprehensive review of information sources. This report provides detailed sales forecasts, discussions of developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 70 tables and figures and a full interview transcript from our survey. The result is a comprehensive market- and industry-centred report, with detailed analyses and informed opinion to benefit your work. Why you should buy Chinese Pharmaceutical Market Outlook 2009-2024 In this report you will receive the following benefits in particular: • Sales forecasts for the overall Chinese pharma market from 2009 to 2024 • Sales forecasts for top-selling drug categories in that market from 2009 to 2024 • Comprehensive discussions to support the forecasts, including SWOT analysis and discussions of market drivers and restraints • Forecasts for prescription drugs, branded drugs, generics, over-the-counter treatments and the clinical trials market in China • Expert opinion from our original survey on emerging medical trends in China. Crucial questions answered by this report: This report answers important questions such as: • What are the highest-selling drug types in China and how will their sales develop from 2009 onwards? • How will the healthcare stimulus affect sales of diabetes medicines by 2014? • Which companies are investing in China? What types of investments are they making? • What is China’s scientific and technological expertise like? • What domestic pharma companies are making promising developments, and what do their business models suggest about China’s pharma industry? • What does China’s research and development landscape look like for pharma? • Why is China such an important research and development environment for stem cells technologies? • What is the generic drug penetration in China? How will market shares for original-branded and generic drugs change from 2009 onwards? • Why are clinical trials moving to China, and how will that market develop?Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com

The US Pharmaceutical Market 2009-2024

admin — Mon, 04 Jan 2010 14:09:15 +0000

The US Pharmaceutical Market 2009-2024 what will happen next in the world’s largest pharma market? Our new market study explains, letting you know the implications of change. - Including over 65 tables, graphs and figures The United States has by far the world’s largest pharmaceutical market. In the twelve months to Q2 2009, the US accounted for 41% of world pharmaceutical sales. Its vast economy, high standard of living, minimal pricing controls and strong intellectual property rights help make it the world’s most dominant pharma market. The US also has one of the most stringent regulatory environments in the world. This brand new report – US Pharmaceutical Market 2009-2024 – will provide you with extensive information about the US pharma market and industry to benefit your work. This report presents the information you really need to know, to assess this market in light of impending changes. ( http://www.bharatbook.com/detail.asp?id=129532&rt=The-US-Pharmaceutical-Market-2009-2024.html ) US Pharmaceutical Market 2009-2024 gives you current information and analyses you need to understand the following aspects of the US pharmaceuticals market, in particular: • The regulatory environment • The healthcare distribution system • The prevalence and relevance of the insurance industry • The pricing system for pharmaceuticals • Government-run Medicare and Medicaid systems • Direct-to-consumer advertising • The legal and regulatory status of generics. The US has been the world’s most prominent pharma market for a long time, but what will happen next? Can the market sustain growth and, if so, by how much? What will happen when Lipitor’s patent expires? Will the US market for cardiovascular treatments grow or shrink? What about the US market for cancer treatments? This report also includes interviews with three experts – Dr May Mak, Dr Donald Light and Mr Charlie Mayr – to provide additional insight into current market factors, looking ahead. Crucial questions answered by this report – the main benefits of US Pharmaceutical Market 2009-2024 This new report provides a range of vital information, and answers a variety of questions. You will benefit from answers to crucial questions such as the following: • Will the US market grow more quickly from 2009 to 2014, or from 2014 to 2019? • Which treatment categories will grow in value? Which will shrink? • What impact will patent expiries have on the cardiovascular market? On the mental health treatments market? • Why will insulin sales increase significantly? • What regulatory conditions make the US an attractive location for R&D? • Will sales of generic drugs increase by value through to 2024? How much will they increase by volume? • What are the major points of the healthcare reform bills? How will healthcare reform change insurance coverage? • What are the restraints on the US OTC market? What are its drivers? • What is Medicaid Part D? What will happen to pharma revenues if legislation for Part D changes? • What will be THE major growth area for pharmaceuticals in the US from 2010 onwards? Medical spending in the US is the highest per capita in the world. The US is the world-leader in sales and consumption of new drugs, but will this trend continue? How much more growth can the US market achieve? Which aspects of its market will prosper the most from 2009 to 2024? To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129532&rt=The-US-Pharmaceutical-Market-2009-2024.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook

International Standards for Pharmaceutical Packaging Market Forecasts

admin — Sun, 03 Jan 2010 08:05:53 +0000

The Future of the Pharmaceutical Packaging Industry – Emerging Economies Poised to Capitalize on Increasing Demand

Summary “The Future of the Pharmaceutical Packaging Industry – Emerging Economies Poised to Capitalize on Increasing Demand” which provides insights on the global pharmaceutical packaging market and giving information on market forecasts until 2015. Further, the geographical distribution of pharmaceutical packaging manufacturers across key geographies such as the US, the top five countries in the European region, and Japan are also provided in the report. Key cost and developmental issues are also addressed. The report provides analysis on the competitive landscape including the benchmarking of top companies. Finally, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed. ( http://www.bharatbook.com/detail.asp?id=128491&rt=The-Future-of-the-Pharmaceutical-Packaging-Industry-Emerging-Economies-Poised-to-Capitalize-on-Increasing-Demand.html ) Scope The scope of this report includes: • Detailed market characterization including market size, technology adoption and forecasts until 2015. • Data and analysis on the global pharmaceutical packaging market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan, and the emerging geographies – China, India, Brazil and Russia. • Analysis and review of the key events and milestones that will impact the future of the global e-clinical trial solutions market. Each trend is independently researched to provide qualitative analysis of its implications. • Insightful review of key industry drivers, restraints and challenges which are likely to impact the global pharmaceutical packaging market in the long run. • The report also covers information on the leading market players and the competitive landscape. Key companies covered include are Schott AG, Gerresheimer AG, Duran Group, Nypro Inc., Rexam PLC, Corning Incorporated, and Facet. Reasons to buy The report will enhance your decision making capability and will allow you to: • Develop business strategies by understanding the trends shaping and driving the global pharmaceutical packaging market. • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the pharmaceutical packaging market in the future. • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. • Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage. • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. • What’s the next big thing in global pharmaceutical packaging market landscape? – Identify, understand and capitalize.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=128491&rt=The-Future-of-the-Pharmaceutical-Packaging-Industry-Emerging-Economies-Poised-to-Capitalize-on-Increasing-Demand.html

OrContact us at :Bharat Book Bureau Tel: +91 22 27578668Fax: +91 22 27579131Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook

Indian pharmaceutical market is one of the fastest growing in the world

admin — Fri, 01 Jan 2010 20:34:02 +0000

Indian Pharmaceutical Market Outlook 2009-2024 The rising Indian pharma market will achieve sales of close to $8 billion in 2009 and has enjoyed double-digit growth in the past five years, peaking at 25% in 2007. Will the Indian market continue to achieve high sales growth next decade? Our new report – Indian Pharmaceutical Market Outlook 2009-2024 – explains, providing the information that you need to understand this crucial pharma opportunity. India is of rising importance as growth slows in the current leading markets. ( http://www.bharatbook.com/detail.asp?id=129531&rt=Indian-Pharmaceutical-Market-Outlook-2009-20241.html ) The strong growth registered by the Indian economy has helped to drive its pharmaceutical market and industry. That sector’s growth in recent years has also been driven by India’s expanding middle class, with growing affordability and greater access to healthcare. India currently accounts for over 5% of the Africa/Asia/Australasia market and is ranked 14th in the world pharmaceutical markets. The highly-competitive market in India continues to be dominated by Indian pharmaceutical companies, but remains fragmented, with over 20,000 licensed organisations. Besides many SMEs, competitors include internationally-recognised companies such as Cipla, Dr. Reddy’s and Ranbaxy, as well as foreign multinationals. India’s pharmaceutical industry has strong potential for growth and will continue to be an attractive sector for both domestic and foreign companies, Indian Pharmaceutical Market Outlook 2009-2024 shows. Also, pharmaceutical companies will continue to use acquisitions, joint ventures and leveraging of low operational costs in India. That country’s main strengths include: • Second-largest population in the world, one predicted to overtake China’s by 2035 • World’s second-fastest-growing economy • Growing middle class with dispensable incomes and expanding healthcare provision • Highly-skilled workforce with competitive manufacturing base. Therapeutic sales are not the only source of revenues for India’s pharmaceutical sector. Increasing costs of research and manufacturing have caused pharmaceutical companies worldwide to outsource operations to lower-cost countries. India’s highly competitive pharma industry, with a strong manufacturing base and relatively low overheads, offers strong opportunities for outsourcing both research and production. The growth of India’s pharmaceutical business is mostly driven by: • Increases in production capacity and efficiency • Legislative reforms • The growth in contract manufacturing opportunities there • Increases in outsourcing of clinical trials from higher-cost countries • Research and development capabilities in both small-molecule and biological drugs • Foreign acquisitions and joint ventures by domestic companies. To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129531&rt=Indian-Pharmaceutical-Market-Outlook-2009-20241.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook

Conference on 4th Annual Pharmaceutical Anti-Counterfeiting Strategies

admin — Fri, 01 Jan 2010 14:25:32 +0000

Bharatbook, the leading information aggregator. We facilitate and support the business information needs. With over 90,000 reports, you can get instant access and insights on the studies in you for market research, corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more your areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
wholesale swarovski crystals

Biotech APIs to Post Stronger Gains in the Asia Pacific Active Pharmaceutical Ingredients Market

admin — Fri, 01 Jan 2010 07:49:42 +0000

Asia Pacific Active Pharmaceutical Ingredients Market Analysis and ForecastsThis report will provide an analysis of the Active Pharmaceutical Ingredients market in key countries of Asia Pacific region. The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients market in Asia Pacific. The pricing trend of the market will also be analyzed in the report. This report also contains detailed market share analysis of top companies operating in all the major regions. ( http://www.bharatbook.com/Market-Research-Reports/Asia-Pacific-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts.html ) Scope – Detailed analysis of volumes and revenues of Active Pharmaceutical Ingredients in all the major countries and forecasts till 2020 – Detailed analysis of the end applications of Active Pharmaceutical Ingredients in all the major countries – Detailed analysis and forecasts of Active Pharmaceutical Ingredients prices in all the major countries – Thorough analysis of key drivers of growth of the Active Pharmaceutical Ingredients market in all the major countries – Detailed analysis of the market share of the major Active Pharmaceutical Ingredients producing companies in the major countries Reasons to buy – The report acts as a guide to the industry professionals and beginners to gain significant understanding about the Active Pharmaceutical Ingredients market in Asia Pacific – To identify the most attractive geographies, markets and sectors to increase business – Develop custom strategies based on the current and forecasted trends in the volumes and revenues of Active Pharmaceutical Ingredients market – Benchmark different geographies by the historic and forecasted growth of volumes and revenues of Active Pharmaceutical Ingredients and the drivers, restraints and challenges unique to each of the major regions – Benchmark your company with the top Active Pharmaceutical Ingredient producers with comprehensive information of the market share of top companies operating in each of the major regions

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Asia-Pacific-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts.html

OrContact us at :Bharat Book BureauTel: +91 22 27578668Fax: +91 22 27579131Email: press@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com

Report on Indian Pharmaceuticals & Healthcare Industry

admin — Thu, 31 Dec 2009 20:31:06 +0000

Pharmaceuticals & Healthcare Report India The India Pharmaceuticals and Healthcare Report has been researched at source and features the latest available data and forecasts to 2011 covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; company rankings and competitive landscapes including multinational and national drugs companies; and analysis of latest industry news, trends and regulatory developments. ( http://www.bharatbook.com/Market-Research-Reports/Pharmaceuticals-Healthcare-Report-India.html ) India Pharmaceuticals and Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Indian pharmaceutical and healthcare industry. We find this to be a concise view of the leading pharmaceutical companies in India. It allows us to focus on certain companies to determine if we need to initiate further research on their overall direction. Independent 5-year pharmaceutical and healthcare industry forecasts for India. Original pharmaceutical and healthcare market research and pharmaceutical and healthcare sector trend analysis for the Indian pharmaceutical and healthcare industry. Competitive intelligence, Indian pharmaceutical and healthcare company rankings and SWOT analyses on international and domestic pharmaceutical and healthcare companies in the Indian market. Key Benefits of Report * Benchmark It’s Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on India to test other views – a key input for successful budgeting and strategic business planning in the Indian pharmaceutical and healthcare market. * Target Business Opportunities & Risks in the Indian Pharmaceutical and Healthcare Sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in India. * Exploit The Latest Competitive Indian Pharmaceutical and Healthcare Intelligence & company SWOTS on your competitors and peers through company rankings by sales, market share and ownership structure – includes multi-national and national companies in India. Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com